A retrospective study of pharmacist-supported mirogabalin treatment highlights the need for careful evidence interpretation and sustained follow-up in cancer-related neuropathic pain.
|Articles|July 6, 2022
Daily OTC Pearl: Legatrin PM
Author(s)Saro Arakelians, PharmD
Legatrin PM is intended for relief of lower body pain.
Advertisement
OTC/Lifestyle Pearl of the Day: Legatrin PM
Indication: Legatrin PM is intended for relief of lower body pain.
Insight:
- Active Ingredients (per Caplet): Acetaminophen (500 mg), diphenhydramine HCl (50 mg). Inactive ingredients: croscarmellose sodium, D&C red No. 27 lake, dicalcium phosphate, FD&C blue no. 1 lake, FD&C red no. 40 lake, FD&C yellow no. 6 lake, hydroxypropyl methylcellulose, magnesium silicate, magnesium stearate, microcrystalline cellulose, mineral oil, polyethylene glycol, stearic acid, titanium dioxide.
- Directions: Adults and children 12 years of age and older: 1 caplet at bedtime or as directed by a physician. Do not give to children under the age of 12 years unless directed by your physician. Do not exceed recommended dosage. Store at room temperature.
- Consult a physician before use if you have glaucoma; breathing problems such as asthma, emphysema, chronic bronchitis or pulmonary disease; trouble urinating due to an enlarged prostate gland.
Advertisement
Related to this article
In more than 262,000 UK Biobank participants, a 5-marker cardiometabolic score was linked to graded risk at each step toward CKM multimorbidity.
Two IDWeek 2026 studies link influenza vaccination to fewer ICU admissions in older adults and fewer emergency visits in children.
The approval offers a once-weekly basal insulin treatment option for patients, reducing the frequency of injections.
Early data suggest the 7 PCV20-added serotypes are causing a smaller share of invasive pneumococcal disease in children younger than 2 years.
In pooled CORALreef data, patients with eGFR below 60 had a 65.9% placebo-adjusted LDL-C reduction at week 24, with safety comparable to placebo.
A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.
Understanding local health care priorities is essential to developing meaningful solutions.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
2
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
3
CagriSema Tied to 25% Weight Loss in Women, Post Hoc Data Show
4
Kidney Week 2026: What to Know for Nephrology's Biggest Meeting
5